Skip to content

Clinical study on effectiveness of diabetic diet containing rare sugar D-allulose in patients with type 2 diabetes

Single-blind crossover comparative study on effectiveness of diabetic diet containing rare sugar D-allulose in patients with type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs061200022
Enrollment
24
Registered
2020-10-14
Start date
2020-12-03
Completion date
Unknown
Last updated
2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

A: Diabetes diet precedent group After being hospitalized, eat a diabetic diet three times a day for two days. After a washout period of 1 day, a rare sugar-containing diabetic diet is taken 3 times a

Sponsors

Imachi Hitomi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with type 2 diabetes whose age at the time of obtaining consent is 20 to 80 years old. 2. Hospitalized type 2 diabetic patients. (HbA1c 6.5% or more) 3. Patients with written informed consent to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Patients taking an a-glucosidase inhibitor 2. Patients with a history of serious side effects after taking D-allulose in the past 3. Pregnant, maternity, lactating or potentially pregnant women 4. Patients with severe renal impairment (serum creatinine level of 1.5 mg/dl or higher) 5. Patients with other serious complications 6. Patients participating in other trials 7. According to the opinion of the investigator, etc., if participation in the research does not maximize the benefit of the research target (such as impairing the welfare of the research target), or obstructing, limiting, or confusing the evaluation specific to the clinical research implementation plan. If it is determined to do. 8. Under the direction of the investigator, etc. or the conducting medical institution, the investigator of the investigator or the conducting medical institution directly involved in this research or other clinical research, or such employee or the investigator Family

Design outcomes

Primary

MeasureTime frame
The postprandial blood glucose peak value is comparatively examined using a Flash Glucose Monitoring.

Secondary

MeasureTime frame
AUC 2 hours after meal when using continuous blood glucose meter Blood/urine D allulose concentration Questionnaire of patient satisfaction including seasoning Change in weight change Control status of diabetes before and after ingestion of each diet group Changes in various laboratory test values

Contacts

Public ContactKensaku Fukunaga

Kagawa University hospital

fukunaga.kensaku@kagawa-u.ac.jp+81-87-891-2230

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026